Merck

Merck, a leading science and technology company, generated total revenues of €22,2 billion in 2022 with its divisions Healthcare, Electronics and Life Science.

Links

Website Transparency Register Profile

ID: 49654992078-52

Lobbying Activity

Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur)

20 Nov 2025 · Health Policy

Meeting with Gabriela Firea (Member of the European Parliament) and European Students' Union

13 Nov 2025 · Shaping Europe Together:Youth Priorities for 2025-2029

Meeting with Nina Carberry (Member of the European Parliament)

28 Oct 2025 · Equine Health Technologies

Meeting with Gabriela Firea (Member of the European Parliament) and European Students' Union

27 Oct 2025 · Preparation of Shaping Europe Together:Youth Priorities for 2025-2029

Meeting with Eva Schultz (Cabinet of Executive Vice-President Roxana Mînzatu)

20 Oct 2025 · Meeting on the fertility matters in relation to EU Gender Equality and Demography Strategies

Meeting with Alexandr Hobza (Cabinet of Executive Vice-President Stéphane Séjourné) and

15 Oct 2025 · Exchange of views on regulatory environment for Life Sciences Manufacturing sector

Meeting with Sonia Vila Nunez (Cabinet of Executive Vice-President Roxana Mînzatu) and

1 Oct 2025 · To formally present and discuss the Movement +Fertility, and the Portuguese Manifesto for reproductive equality and a sustainable future.

Response to Commission Communication on a EU Cardiovascular Health Plan

12 Sept 2025

Meeting with Boriša Falatar (Cabinet of Commissioner Hadja Lahbib)

9 Sept 2025 · gender equality and strengthening health preparedness

Response to COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS Gender Equality Strategy 2026-2030

23 Jul 2025

Meeting with Olivér Várhelyi (Commissioner)

10 Jul 2025 · Exchange of views on the EU pharma and health policy matters

Meeting with Gabriela Tschirkova (Cabinet of Commissioner Valdis Dombrovskis), Zaneta Vegnere (Cabinet of Commissioner Valdis Dombrovskis)

10 Jul 2025 · competitiveness

Meeting with Jana Dabbelt (Cabinet of Commissioner Olivér Várhelyi)

3 Jul 2025 · • Intro to company • pharma legislation and CMA • UWWTP and health-specific policies (mental health, fertility, cancer and cardiovascular health)

Meeting with Giulia Del Brenna (Head of Unit Internal Market, Industry, Entrepreneurship and SMEs) and

1 Jul 2025 · The specifics of life science-related upcoming initiatives, including the new Bioeconomy Strategy, the Biotech Act, and Life Science Strategy.

Meeting with Michael McGrath (Commissioner) and

27 Jun 2025 · Exchange of views on issues relating to competitiveness and corporate sustainability

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

11 Jun 2025

Meeting with Sven Simon (Member of the European Parliament)

10 Jun 2025 · Innovation und nachhaltiges Wachstum: Ein Realitätscheck für Europas strategische Ambitionen

Response to COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS: A European Strategy for AI in science – paving the way for a European AI research council

4 Jun 2025

Response to Apply AI Strategy: strengthening the AI continent

4 Jun 2025

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

26 May 2025 · New EU Pharmaceutical Legislation

Meeting with Olivier Girard (Head of Unit Health Emergency Preparedness and Response Authority)

21 May 2025 · Discussion on availability and access to medical countermeasures manufactured by Merck

Meeting with Alisa Tiganj (Cabinet of Commissioner Christophe Hansen), Antonella Rossetti (Cabinet of Commissioner Christophe Hansen) and

29 Apr 2025 · Role of animal health sector in contributing to a sustainable livestock sector in the EU; Trade and animal health and agricultural policies; Upcoming livestock strategy: content and timeline; Digitalisation in support of farmers

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

16 Apr 2025

Meeting with Tomislav Sokol (Member of the European Parliament)

8 Apr 2025 · Health policy

Meeting with Peter Agius (Member of the European Parliament)

8 Apr 2025 · Introduction

Meeting with Daniel Caspary (Member of the European Parliament)

7 Apr 2025 · Austausch

Meeting with Maurice Whelan (Head of Unit Joint Research Centre), Tobias Wiesenthal (Head of Unit Joint Research Centre) and

4 Apr 2025 · Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EU) 2019/125 concerning trade in certain goods which could be used for capital punishment, torture or other cruel, inhuman or degrading treatment or punishment

1 Apr 2025

Meeting with David Ciliberti (Cabinet of Commissioner Glenn Micallef)

28 Mar 2025 · Introductory meeting

Response to Amendments to Taxonomy Delegated Acts

25 Mar 2025

Meeting with András Tivadar Kulja (Member of the European Parliament)

20 Feb 2025 · European Healthcare

Meeting with Henna Virkkunen (Executive Vice-President) and

15 Feb 2025 · Private roundtable on transatlantic and global cooperation on tech organised on the margins of the Munich Security Conference

Meeting with Eva Maydell (Member of the European Parliament)

15 Feb 2025 · EU Competitiveness Agenda

Meeting with Svenja Hahn (Member of the European Parliament) and

14 Feb 2025 · Exchange on upcoming digital EU legislation

Response to Single Market Strategy 2025

31 Jan 2025

Response to Delegated Act setting out requirements to be followed by digital product passport service providers and a conformity assessment scheme to verify such requirements

9 Dec 2024

Meeting with Peter Liese (Member of the European Parliament) and

4 Dec 2024 · Austausch

Meeting with András Tivadar Kulja (Member of the European Parliament)

12 Nov 2024 · Brain health

Meeting with Nicolás González Casares (Member of the European Parliament)

15 Oct 2024 · Non-communicable diseases

Meeting with Tomislav Sokol (Member of the European Parliament)

15 Oct 2024 · Health policy

Response to Commission Roadmap towards ultimately phasing out animal testing for chemical safety assessments

14 Oct 2024

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulations (EC) No 178/2002, (EC) No 401/2009, (EU) 2017/745 and (EU) 2019/1021 of the European Parliament and of the Council as regards the re-attribution of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals

21 Mar 2024

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL establishing a common data platform on chemicals, laying down rules to ensure that the data contained in it are findable, accessible, interoperable and reusable and establishing a monitoring and outlook framework for chemicals

21 Mar 2024

Meeting with Henrike Hahn (Member of the European Parliament, Shadow rapporteur) and

21 Mar 2024 · Critical Raw Materials

Meeting with Frédérique Ries (Member of the European Parliament, Shadow rapporteur)

25 Jan 2024 · Revision of the Pharmaceutical Legislation

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

11 Jan 2024 · Cardiovascular health

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and EuropaBio

11 Oct 2023 · Directive on Medicinal products for human use

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

9 Oct 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

9 Oct 2023

Meeting with Martin Hojsík (Member of the European Parliament, Rapporteur)

5 Oct 2023 · REACH, Soil

Meeting with Johan Nissinen (Member of the European Parliament)

21 Sept 2023 · läkemedel

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and

7 Sept 2023 · Revision of the Pharmaceutical Legislation (staff level)

Meeting with Karsten Lucke (Member of the European Parliament)

29 Jun 2023 · COVI Report / R&D

Meeting with César Luena (Member of the European Parliament)

7 Jun 2023 · EU Pharmacuetical Strategy

Meeting with Elina Melngaile (Cabinet of Executive Vice-President Valdis Dombrovskis), Zaneta Vegnere (Cabinet of Executive Vice-President Valdis Dombrovskis) and

5 Jun 2023 · Trade & Technology Council, Global Steel and Aluminum Arrangement, Critical Minerals Agreement

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

18 Apr 2023 · Medicines

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

30 Mar 2023

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur) and Stryker

23 Mar 2023 · Medicines

Meeting with Ibán García Del Blanco (Member of the European Parliament)

2 Mar 2023 · Exchange of views on the Intellectual Property, Data Act and AI

Meeting with Valdis Dombrovskis (Executive Vice-President)

18 Feb 2023 · Review of pharmaceutical legislation. TRIPS waiver.

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

1 Feb 2023 · Lessons learned on impact of COVID-19 pandemic

Meeting with Mariya Gabriel (Commissioner)

18 Jan 2023 · Deep tech innovation for life sciences & biological components EU Innovation Agenda EU Mission on cancer R&I for health EU Research on semi-conductors

Meeting with Dan Nica (Member of the European Parliament, Rapporteur)

12 Dec 2022 · Dinner debate on Chips Act

Meeting with Lesia Radelicki (Cabinet of Commissioner Helena Dalli)

8 Nov 2022 · Share initiatives and explore ways of collaboration and synergy

Meeting with Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

7 Sept 2022 · Revision of the pharmaceutical legislation.

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on harmonised rules on fair access to and use of data (Data Act)

13 May 2022

Meeting with Aliénor Margerit (Cabinet of Commissioner Paolo Gentiloni)

4 Apr 2022 · Current issues such as the transformation of the European economy, and how the Chemical and Pharmaceutical industry

Meeting with Tom Berendsen (Member of the European Parliament, Rapporteur)

16 Feb 2022 · Industry Strategy - Pharmaceutical ecosystem

Meeting with Margaritis Schinas (Vice-President) and

30 Nov 2021 · Pharma Strategy

Meeting with Caroline Boeshertz (Cabinet of Executive Vice-President Valdis Dombrovskis), Elina Melngaile (Cabinet of Executive Vice-President Valdis Dombrovskis), Kevin Keary (Cabinet of Executive Vice-President Valdis Dombrovskis) and

26 Oct 2021 · Pharmaceutical sector – trade related issues

Meeting with Mauro Raffaele Petriccione (Director-General Climate Action)

3 Sept 2021 · FF55 and the pharmaceutical industry

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL LAYING DOWN HARMONISED RULES ON ARTIFICIAL INTELLIGENCE (ARTIFICIAL INTELLIGENCE ACT) AND AMENDING CERTAIN UNION LEGISLATIVE ACTS

5 Aug 2021

Meeting with Romana Jerković (Member of the European Parliament)

1 Jun 2021 · Pharmaceutical strategy

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

26 Apr 2021

Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

12 Apr 2021 · Global supply chains for disposables

Meeting with Thierry Breton (Commissioner)